Is it time for interferon in low-risk patients with polycythaemia vera?

被引：2
|
作者：
Heibl, Sonja [1 ]
机构：
[1] Klinikum Wels Grieskirchen, A-4600 Wels, Austria
来源：
LANCET HAEMATOLOGY | 2021年 / 8卷 / 03期
关键词：
D O I：
10.1016/S2352-3026(20)30434-8
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E162 / E163
页数：2
相关论文
共 50 条
  • [1] Interferon treatment in polycythaemia vera
    Reilly, JT
    Vellenga, E
    DeWolff, JTM
    [J]. LEUKEMIA & LYMPHOMA, 1996, 22 : 143 - +
  • [2] Effectiveness of interferon alpha in polycythaemia vera - A prospective analysis
    Hansmann, E
    Bremer, K
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 885 - 885
  • [3] Ropeginterferon alfa-2b versus phlebotomy in low-risk patients with polycythaemia vera (Low-PV study): a multicentre, randomised phase 2 trial
    Barbui, Tiziano
    Vannucchi, Alessandro Maria
    De Stefano, Valerio
    Masciulli, Arianna
    Carobbio, Alessandra
    Ferrari, Alberto
    Ghirardi, Arianna
    Rossi, Elena
    Ciceri, Fabio
    Bonifacio, Massimiliano
    Iurlo, Alessandra
    Palandri, Francesca
    Benevolo, Giulia
    Pane, Fabrizio
    Ricco, Alessandra
    Carli, Giuseppe
    Caramella, Marianna
    Rapezzi, Davide
    Musolino, Caterina
    Siragusa, Sergio
    Rumi, Elisa
    Patriarca, Andrea
    Cascavilla, Nicola
    Mora, Barbara
    Cacciola, Emma
    Mannarelli, Carmela
    Loscocco, Giuseppe Gaetano
    Guglielmelli, Paola
    Betti, Silvia
    Lunghi, Francesca
    Scaffidi, Luigi
    Bucelli, Cristina
    Vianelli, Nicola
    Bellini, Marta
    Finazzi, Maria Chiara
    Tognoni, Gianni
    Rambaldi, Alessandro
    [J]. LANCET HAEMATOLOGY, 2021, 8 (03): : E175 - E184
  • [4] Management Issues and Controversies in Low-Risk Patients with Essential Thrombocythemia and Polycythemia Vera
    How, Joan
    Hobbs, Gabriela
    [J]. CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2021, 16 (05) : 473 - 482
  • [5] Management Issues and Controversies in Low-Risk Patients with Essential Thrombocythemia and Polycythemia Vera
    Joan How
    Gabriela Hobbs
    [J]. Current Hematologic Malignancy Reports, 2021, 16 : 473 - 482
  • [6] SURGICAL OBSERVATIONS IN POLYCYTHAEMIA VERA PATIENTS
    NAGY, G
    TOMPA, G
    [J]. ACTA MEDICA ACADEMIAE SCIENTIARUM HUNGARICAE, 1971, 28 (01) : 7 - &
  • [7] Endothelial dysfunction in patients with polycythaemia vera
    Neunteufl, T
    Heher, S
    Stefenelli, T
    Pabinger, I
    Gisslinger, H
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2001, 115 (02) : 354 - 359
  • [8] Leukocytosis at Diagnosis and the Risk of Subsequent Thrombosis in Patients With Low-Risk Essential Thrombocythemia and Polycythemia Vera
    Gangat, Naseema
    Wolanskyj, Alexandra P.
    Schwager, Susan M.
    Hanson, Curtis A.
    Tefferi, Ayalew
    [J]. CANCER, 2009, 115 (24) : 5740 - 5745
  • [9] Leukaemic risk in polycythaemia vera and essential thrombocytopenia
    Kwong, YL
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 1996, 56 (1-2) : 90 - 91
  • [10] Therapeutic efficacy of recombinant interferon-alpha in polycythaemia vera
    Öztürk, A
    Günay, A
    Üskent, N
    [J]. ACTA HAEMATOLOGICA, 1998, 99 (02) : 89 - 91
12345